http://www.modernmedicine.com/modernmedicine/Cataracts/Article/list/46551 Visit ModernMedicine.com, a medical resource for physicians, to find coding and formulary tools, free CME, patient education, medical news and articles, and more. 2009-11-21T22:27:56Z http://www.modernmedicine.com/modernmedicine/Retinal+Disease/Cataract-Surgery-Unlikely-to-Affect-the-Progressio/ArticleNewsFeed/Article/detail/642025?contextCategoryId=46551&ref=25 In patients with non-neovascular age-related macular degeneration (AMD), cataract surgery is not associated with an increased risk of AMD progression. In addition, dietary fats may have differential effects on the risk of AMD, according to two studies in the November issue of the Archives of Ophthalmology. 2009-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025/SS36006.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025null XML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Abbott-completes-acquisition-of-Visiogen/ArticleStandard/Article/detail/639005?contextCategoryId=46551&ref=25 Abbott Laboratories has completed its acquisition of privately held eye-care company Visiogen, adding to its vision-care business an accommodating IOL technology (Synchrony) designed to address presbyopia in patients with cataracts. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639005null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/New-documentary-explores-life-of-Dr-Kelman/ArticleStandard/Article/detail/638990?contextCategoryId=46551&ref=25 "Through My Eyes: The Charlie Kelman Story," a 1-hour documentary about the ophthalmologist who developed the phacoemulsification technique of cataract removal, will premiere nationwide on public television Jan. 20, 2010, at 9 p.m. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/638990null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Ellex-unveils-new-generation-of-diagnostic-ultraso/ArticleStandard/Article/detail/639015?contextCategoryId=46551&ref=25 Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639015null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Carl-Zeiss-Meditec-introduces-new-treatment-workfl/ArticleStandard/Article/detail/639039?contextCategoryId=46551&ref=25 Carl Zeiss Meditec introduced its new suite of treatment workflow and data management systems at the annual meeting of the American Academy of Ophthalmology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639039null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Bausch-amp-Lomb-subsidiaries-CROMA-to-co-promote-b/ArticleStandard/Article/detail/631233?contextCategoryId=46551&ref=25 Several subsidiaries of Bausch & Lomb have been granted rights from CROMA Pharma GmbH to co-promote and sell bromfenac ophthalmic solution in Europe when it becomes available to that market, announced Bausch & Lomb. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631233null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/AMO-launches-online-ordering-service/ArticleStandard/Article/detail/631232?contextCategoryId=46551&ref=25 Abbott Medical Optics (AMO) has launched a new online ordering service (AMOeasy, www.amoeasy.com) whereby customers can order the company?s implants and other cataract-related products as well as track orders at any time of day. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631232null HTML http://www.modernmedicine.com/modernmedicine/Nursing/Childhood-Nephrotic-Syndrome-Can-Cause-Lifelong-Il/ArticleNewsFeed/Article/detail/629418?contextCategoryId=46551&ref=25 Children with minimal-change nephrotic syndrome are at increased risk for osteoporosis, hypertension, sperm abnormalities and cataracts if the condition persists beyond puberty, according to a study published online Sept. 24 in the Clinical Journal of the American Society of Nephrology. 2009-09-25T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418/kidney2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Femtosecond-laser-receives-clearance-for-capsuloto/ArticleStandard/Article/detail/626558?contextCategoryId=46551&ref=25 LenSx Lasers Inc. announced that the FDA has granted 510(k) clearance for its femtosecond laser used for anterior capsulotomy during cataract surgery. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626558null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-care-patient-satisfaction-is-weighed-with-onli/ArticleStandard/Article/detail/627821?contextCategoryId=46551&ref=25 The co-authors conducted two studies to determine patient satisfaction related to their cataract-IOL surgeries, based on online health forums. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627821null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Sulcus-placement-of-a-proprietary-three-piece-mult/ArticleStandard/Article/detail/627822?contextCategoryId=46551&ref=25 Sulcus placement of a proprietary three-piece multifocal IOL (ReZoom, Abbott Medical Optics) is a viable option in eyes in which capsular bag support is not adequate to ensure good lens stability. Then, if the lens decenters in the sulcus, scleral suturing is a safe and effective option for recentering the IOL and restoring good vision. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627822null XML http://www.modernmedicine.com/modernmedicine/Feature+Articles/Abbott-to-buy-Visiogen-for-400-million/ArticleStandard/Article/detail/624117?contextCategoryId=46551&ref=25 Abbott announced a definitive agreement to acquire Visiogen Inc. for $400 million, providing the company with a next-generation accommodating IOL technology to address presbyopia for patients with cataracts. 2009-09-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/624117null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-to-seek-bromfenac-label-change/ArticleStandard/Article/detail/623208?contextCategoryId=46551&ref=25 ISTA Pharmaceuticals plans to ask the FDA to approve a change to the label of its bromfenac 0.09% ophthalmic solution after obtaining positive preliminary phase III results in a confirmatory clinical study of once-daily bromfenac (Xibrom QD) for the treatment of inflammation and pain after cataract surgery. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623208null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Microincisional-IOL-debuts-for-cataract-surgery/ArticleStandard/Article/detail/627654?contextCategoryId=46551&ref=25 The first microincisional IOL (Akreos MICS IOL, Bausch & Lomb) has been introduced in the U.S. market. The lens is a single-piece hydrophilic acrylic IOL designed for delivery through a 1.8-mm incision. Its material and design offer several advantages, according to three surgeons who have used it. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627654null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Anti-inflammatory-for-cataract-surgery-reaches-pha/ArticleStandard/Article/detail/621767?contextCategoryId=46551&ref=25 Preliminary phase III results were released for bromfenac ophthalmic solution 0.09% (Xibrom, ISTA Pharmaceuticals), meant to treat the inflammation and pain following cataract surgery. 2009-08-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/352009/621767null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Survey-shows-cataract-surgery-times-can-be-decreas/ArticleStandard/Article/detail/619783?contextCategoryId=46551&ref=25 Ambulatory centers performing cataract extraction with lens insertion can reduce their procedure times and improve efficiencies, safety, and patient satisfaction, according to a survey conducted by the Accreditation Association for Ambulatory Health Care Institute for Quality Improvement. 2009-08-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619783null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IOL-explantation-trends-shifting-American-Society-/ArticleStandard/Article/detail/619324?contextCategoryId=46551&ref=25 The most recent results from the 2008 American Society of Cataract and Refractive Surgery/European Society of Cataract and Refractive Surgeons survey on foldable IOLs requiring removal or other secondary intervention highlight changes over time in the complications associated with various lens types. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619324null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmic-viscosurgical-device-choices-mean-optim/ArticleStandard/Article/detail/619331?contextCategoryId=46551&ref=25 The large variety of available OVDs allows the surgeon to tailor the surgery to meet any specific needs a patient may have. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619331null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dispersive-cohesive-ophthalmic-surgical-device-out/ArticleStandard/Article/detail/619330?contextCategoryId=46551&ref=25 One surgeon's preference for an ophthalmic surgical device (OVD) of 1.6% sodium hyaluronate (Amvisc Plus, Bausch & Lomb) was reinforced by a study that found it superior to another OVD during phaco and OVD removal. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619330null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Biaxial-phaco-with-torsional-ultrasound-enhanced-w/ArticleStandard/Article/detail/619328?contextCategoryId=46551&ref=25 A new phaco tip (Fine OZil Tip, MicroSurgical Technology) for use with a proprietary handpiece (OZil, Alcon Laboratories) improves the safety and efficiency of phacoemulsification using torsional ultrasound with a biaxial microincisional technique. Modification of the phaco parameters improves chopping and segment removal. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619328null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Fluidics-controlled-longitudinal-transversal-phaco/ArticleStandard/Article/detail/619322?contextCategoryId=46551&ref=25 The current version of a proprietary phaco system (WhiteStar Signature, Abbott Medical Optics) features fluidics control software that allows automatic switching from longitudinal ultrasound to transversal (Ellips) on recognition of occlusion and back again to longitudinal on occlusion break. Results of a prospective study show the benefits of this technology for optimizing the efficiency of cataract removal. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619322null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ketorolac-tromethamine-045-approved-by-FDA/ArticleStandard/Article/detail/619323?contextCategoryId=46551&ref=25 Ketorolac tromethamine 0.45% (Acuvail, Allergan) is a preservative-free ophthalmic NSAID recently approved for twice-daily use in treating pain and inflammation after cataract surgery. Its novel formulation is designed to promote drug delivery and tolerability. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619323null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dual-linear-phacoemulsification-platform-separates/ArticleStandard/Article/detail/619333?contextCategoryId=46551&ref=25 A dual-linear phacoemulsification platform (available on the Stellaris, Bausch & Lomb) separates phaco and vacuum, allowing cataract surgeons to maximize their control over the cataract removal procedure. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619333null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eyes-with-intraoperative-floppy-iris-syndrome-are-/ArticleStandard/Article/detail/619325?contextCategoryId=46551&ref=25 Surgeons discuss their preferences and techniques for using various ophthalmic viscosurgical devices in eyes with intraoperative floppy iris syndrome. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619325null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/23-sodium-hyaluronate-functions-as-unique-surgical/ArticleStandard/Article/detail/619327?contextCategoryId=46551&ref=25 An ophthalmic viscosurgical device of 2.3% sodium hyaluronate (Healon 5, Abbott Medical Optics) makes one ophthalmologist's prechopping-assisted phacoemulsification technique safer and easier, he says. 2009-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/342009/619327null XML http://www.modernmedicine.com/modernmedicine/Endocrinology/Cataract-Surgery-Associated-With-Diabetic-Eye-Prob/ArticleNewsFeed/Article/detail/617424?contextCategoryId=46551&ref=25 Phacoemulsification surgery for cataracts in patients with diabetes is associated with higher rates of new or progressing diabetic retinopathy in the following year, according to research published in the August issue of Ophthalmology. 2009-08-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617424/eyechart_59082.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617424null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Researchers-uncover-genetic-link-to-age-related-ca/ArticleStandard/Article/detail/615695?contextCategoryId=46551&ref=25 Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. 2009-08-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/312009/615695null HTML http://www.modernmedicine.com/modernmedicine/Cataract/Ketolorac-tromethamine-should-be-available-in-Sept/ArticleStandard/Article/detail/615682?contextCategoryId=46551&ref=25 Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. 2009-08-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/312009/615682null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Tamsulosin-intraoperative-floppy-iris-syndrome-lin/ArticleStandard/Article/detail/617060?contextCategoryId=46551&ref=25 A recent article in the Journal of the American Medical Association, an editorial in American Family Physician, articles in the general media outlets, and an updated patient advisory statement from the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology aim to further education primary care physicians and patients about the association between a patient's use of tamsulosin and complications or difficulty during cataract surgery. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/322009/617060null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pars-plana-vitrectomy-risks-mandate-careful-undert/ArticleStandard/Article/detail/617061?contextCategoryId=46551&ref=25 Cataract surgeons confronted by capsular rupture with vitreous prolapse usually favor performing limbal vitrectomy over using a pars plana approach. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/322009/617061null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Moxifloxacin-soaked-IOLs-provide-clinically-releva/ArticleStandard/Article/detail/617070?contextCategoryId=46551&ref=25 A hydrophilic IOL (Afinity CQ2015, STAAR Surgical) seems to be a more efficient delivery system of moxifloxacin 0.5% (Vigamox, Alcon Laboratories) than a hydrophobic IOL (AcrySof SA60, Alcon Laboratories), according to the results of a comparison of lenses soaked in the antibiotic. Both lenses appear to be capable of delivering antibiotics to achieve clinically relevant levels, however. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/322009/617070null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antihypertensive-Drugs-Associated-With-Cataracts/ArticleNewsFeed/Article/detail/613458?contextCategoryId=46551&ref=25 Patients treated with beta blockers for hypertension are more likely than their counterparts not using the drugs to develop cataracts and require cataract surgery, according to a study published online July 23 in the British Journal of Ophthalmology. 2009-07-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613458/eye_SS36015.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613458null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lens-epithelial-cell-evacuation-techniques-not-suf/ArticleStandard/Article/detail/606433?contextCategoryId=46551&ref=25 Current methods used to evacuate the capsule of lens epithelial cells and other lens material are not sufficient to prevent late complications stemming from the resultant Soemmerring's ring formation, namely posterior capsule opacification in adults and unwanted fibrosis in children after cataract surgery, according to the results of one study. Therefore, the researchers suggest that new approaches to basic phacoemulsification should be explored. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606433null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Endophthalmitis-risk-can-be-reduced-by-the-right-a/ArticleStandard/Article/detail/606440?contextCategoryId=46551&ref=25 In a 10-year study of more than 30,000 cataract extractions, faulty wounds were found to be the number one risk factor for the development of endophthalmitis. Appropriate antibiotic therapy also should be in place during and immediately after surgery, because delaying antibiotics to postoperative day 1 increased the risk of endophthalmitis more than 13-fold, according to the study results. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606440null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dual-optic-accommodating-IOL-provides-superior-acu/ArticleStandard/Article/detail/606439?contextCategoryId=46551&ref=25 In a prospective, randomized trial of 90 bilateral cataract patients, those who received an investigational dual-optic accommodating IOL (Synchrony, Visiogen) had better visual acuity and higher reading speeds at intermediate distances compared with patients who received an apodized diffractive multifocal IOL (AcrySof ReSTOR, Alcon Laboratories). 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606439null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Optical-biometer-provides-more-data-than-original-/ArticleStandard/Article/detail/606437?contextCategoryId=46551&ref=25 In a side-by-side comparison of 35 patients, a new optical biometer (LenStar LS900, Haag-Streit) was found to provide more data per examination than the only previously available optical biometer (IOLMaster, Carl Zeiss Meditec), but the examination with the new model took longer to complete. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606437null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Negative-dysphotopsia-an-enigma/ArticleStandard/Article/detail/606443?contextCategoryId=46551&ref=25 Negative dysphotopsia can lead to tremendous dissatisfaction in patients with pseudophakia. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606443null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/The-future-of-cataract-surgery-Improved-ergonomics/ArticleStandard/Article/detail/606444?contextCategoryId=46551&ref=25 A "heads up" high-definition, three-dimensional (3-D) system allows surgeons to perform cataract procedures without hunching over a standard microscope. In addition to the improved ergonomics, the system has wide-ranging applications for patient and surgeon education, and by using the 3-D format and overlaying graphics and metrics, holds promise to optimize results and safety margins in cataract surgery and other procedures. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606444null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lens-epithelial-cells-effectively-removed-from-cap/ArticleStandard/Article/detail/606438?contextCategoryId=46551&ref=25 An in vitro study was performed evaluating laser photolysis using a modified Nd:YAG laser (A.R.C. Laser) to remove lens epithelial cells (LECs) from the capsular bag. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606438null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Simultaneous-bilateral-cataract-surgery-a-safe-pro/ArticleStandard/Article/detail/606436?contextCategoryId=46551&ref=25 Although many ophthalmic surgeons avoid performing simultaneous bilateral cataract surgery because of the perceived risk of bilateral simultaneous endophthalmitis, the risk of the complication is actually miniscule when proper infection control and anti-cross-contamination procedures are followed. As refractive lens procedures are increasingly performed on younger patients, it is likely that the simultaneous bilateral procedure will become more common. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606436null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Coaxial-microincisional-cataract-surgery-results-i/ArticleStandard/Article/detail/606441?contextCategoryId=46551&ref=25 Results of a retrospective study comparing groups of eyes undergoing phacoemulsification using a coaxial 1.8-mm microincisional technique versus through a standard 2.8-mm incision showed that the flare/cell reaction in the anterior chamber early after surgery was significantly less in the microincisional group. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606441null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-surgery-Phacoemulsification-fluidics-char/ArticleStandard/Article/detail/606434?contextCategoryId=46551&ref=25 Better understanding of the effects of ultrasound modality as well as phacoemulsification tip type and orientation can help to optimize the efficiency and safety of cataract surgery. Jaime Zacharias, MD, has implemented novel methodology to gather this information. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606434null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Transversal-ultrasound-Phacoemulsification-with-le/ArticleStandard/Article/detail/606435?contextCategoryId=46551&ref=25 Transversal ultrasound that blends side-to-side and longitudinal ultrasound into an elliptical movement is an effective phacoemusification tool, particularly for dense cataracts. In an open-label, non-randomized comparative study of 331 patients who received phaco via a transversal ultrasound system, average effective phaco time and average foot pedal time were both very low. The elliptical motion of transversal ultrasound also reduces repulsion, does not require a bent needle, is useful for trenching and sculpting, and is self-cleaning of nuclear debris. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606435null XML http://www.modernmedicine.com/modernmedicine/Cataract/AAO-ASCRS-issue-advisory-to-cataract-patients-taki/ArticleStandard/Article/detail/602877?contextCategoryId=46551&ref=25 The American Academy of Ophthalmology (AAO) and the American Society of Cataract and Refractive Surgery (ASCRS) have issued a joint statement regarding results of a new study. The new research reinforces an advisory issued in 2006 that cautioned patients taking tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals Inc.) to treat prostate enlargement and urinary problems should inform their ophthalmologist about use of this alpha-blocker before undergoing eye surgery. 2009-06-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/242009/602877null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Corneal-edema-patients-at-higher-risk-for-transpla/ArticleStandard/Article/detail/601688?contextCategoryId=46551&ref=25 The corneal transplant failure rate was four times higher in patients diagnosed with corneal edema associated with either IOL implants or no natural lens following cataract removal, than in patients diagnosed with Fuchs' dystrophy, according to a study. 2009-06-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/232009/601688null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bromfenac-trial-suggests-possibility-of-twice-dail/ArticleStandard/Article/detail/603260?contextCategoryId=46551&ref=25 A prospective, randomized, investigator-masked study was conducted to compare twice-daily and four-times-daily dosing of a corticosteroid after cataract surgery. All patients also received bromfenac 0.09% (Xibrom, Ista Pharmaceuticals). No significant differences in macular thickening or anterior chamber cell and flare were observed between groups. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/242009/603260null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Toric-IOLs-can-be-oriented-by-iris-fingerprinting/ArticleStandard/Article/detail/599622?contextCategoryId=46551&ref=25 Toric IOLs are precision devices that improve the vision of patients who have cataracts and astigmatism. A new method for orienting these lenses with absolute accuracy, using unique iris landmarks and proprietary software to graph and map it, is designed to help ensure that these lenses are of optimal benefit to these patients. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599622null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Accommodating-lens-offers-improved-visual-acuity-m/ArticleStandard/Article/detail/599619?contextCategoryId=46551&ref=25 A multicenter postmarketing study is under way assessing the effectiveness of the latest generation of an accommodating IOL (Crystalens HD, Bausch & Lomb). Initial results from a 1-month visit show that the lens is associated with a full range of functional vision and improved visual acuities relative to the previous generation of this presbyopia-correcting IOL. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599619null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Toric-IOL-rotational-stability-is-demonstrated-in-/ArticleStandard/Article/detail/599635?contextCategoryId=46551&ref=25 Postoperative rotation of a toric IOL (AcrySof Toric/SN60TT, Alcon Laboratories) was investigated in 30 eyes through analysis of retroillumination photographs taken at 1 hour, 1 month, and 6 months after surgery. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599635null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dual-optic-accommodating-IOL-displays-excellent-in/ArticleStandard/Article/detail/599624?contextCategoryId=46551&ref=25 A randomized trial of 120 eyes in 60 patients compared an investigational dual optic accommodating IOL (Synchrony, Visiogen) with an apodized diffractive aspheric multifocal IOL (AcrySof ReSTOR Aspheric, Alcon Laboratories). Preliminary results in 31 eyes of 18 patients 6 months postoperatively found that distance-corrected distance and near visual results were comparable between the two IOLs and that the dual optic accommodating IOL provided significantly better intermediate visual acuity. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599624null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Multifocal-IOL-mixing-and-matching-is-found-to-be-/ArticleStandard/Article/detail/599628?contextCategoryId=46551&ref=25 Twelve European centers participated in a prospective Web-documented study to investigate mixing and matching of multifocal IOLs with different optical principles. Results from 152 patients seen at a final visit (120 to 180 days after surgery) showed excellent outcomes for visual acuity, functional near vision, and spectacle independence along with a high rate of patient satisfaction. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599628null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Aspheric-multifocal-IOL-study-highlights-benefits-/ArticleStandard/Article/detail/599634?contextCategoryId=46551&ref=25 A prospective, multicenter clinical trial randomly assigned 279 patients to bilateral implantation of the +3.0-D add power multifocal AcrySof IQ ReSTOR IOL (SN6AD1, Alcon Laboratories) or the +4.0-D add power version (SN6AD3, Alcon Laboratories). Assessments at 6 months after surgery, including binocular defocus testing, showed the theoretically expected shift in the best distance for near vision and a significant improvement in intermediate vision with the +3.0-D versus the +4.0-D ReSTOR IOL. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599634null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Wanted-Test-to-screen-multifocal-IOL-candidates-fo/ArticleStandard/Article/detail/599633?contextCategoryId=46551&ref=25 Multifocal IOLs add "noise" to the visual system that can challenge the neural-adaptation abilities of some patients. While the Pelli-Levi Dual Acuity Chart is an effective screen for neuro-sensory pathology, one practitioner said what's needed is a test that will help ophthalmologists identify patients who are likely to have difficulty neural-adapting to a multifocal IOL. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599633null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Aspheric-diffractive-multifocal-IOL-performance-hi/ArticleStandard/Article/detail/599627?contextCategoryId=46551&ref=25 In a U.S. multicenter study, 121 patients underwent bilateral implantation of the aspheric diffractive multifocal IOL (Tecnis Multifocal ZMA00, Abbott Medical Optics). At 1 year, 93% of patients achieved simultaneous distance UCVA of 20/25 or better and 20/32 (~J2) at near (despite disallowing the correction of astigmatism), and about 85% never wore glasses. Unique design features help to explain the outstanding performance of this new multifocal IOL. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599627null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bifocal-IOL-favorable-option-for-cataract-and-refr/ArticleStandard/Article/detail/599632?contextCategoryId=46551&ref=25 Data were collected from a series of 29 patients who underwent bilateral implantation of the aberration-correcting bifocal IOL (Acri.Lisa 366D, Carl Zeiss Meditec). The results are favorable for refractive predictability and both visual acuity and self-rated performance for a variety of daily activities. The majority of patients achieved complete spectacle independence. 2009-05-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599632null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-surgery-and-the-primary-care-practitioner/ArticleStandard/Article/detail/597275?contextCategoryId=46551&ref=25 Pertinent issues surrounding the decision to perform cataract surgery; how various intraocular lens implants are selected; how surgery is now performed; postoperative complications, activities, and care; the role of the primary care physician; and the issue of medical clearance for this procedure. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/geriatrics/192009/597275/0509_rotate_flash.gif XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Astigmatism-measurement-improves-refractive-result/ArticleStandard/Article/detail/599655?contextCategoryId=46551&ref=25 Astigmatism measurement with an intraoperative wavefront aberrometer (ORange, WaveTec Vision Systems) allows evaluation of the effect of limbal relaxing incisions during cataract surgery and the need for enhancement. Results of a multicenter study show that its readings correspond with topographic and refractive cylinder measured preoperatively and postoperatively and that its use improves postoperative refractive results. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599655null XML http://www.modernmedicine.com/modernmedicine/Cataract/Study-compares-M-SICS-phaco-in-charity-camp-popula/ArticleStandard/Article/detail/596431?contextCategoryId=46551&ref=25 To answer the question of whether quality - specifically, uncorrected vision, astigmatism, visual rehabilitation, and safety - is sacrificed when M-SICS is performed instead of phaco, Sanduk Ruit, MD, Geoffrey Tabin, MD, David F. Chang, MD, and colleagues conducted the first prospective, randomized trial of phaco versus M-SICS in a charity camp population. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/192009/596431null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-Three-programs-offer-hope-in-developing-w/ArticleStandard/Article/detail/599640?contextCategoryId=46551&ref=25 Three programs in different geographic areas serve as models of success in addressing cataract in the developing world, the top cause of blindness globally. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599640null XML http://www.modernmedicine.com/modernmedicine/Cataract/ASCRS-New-intraoperative-wavefront-aberrometer-deb/ArticleStandard/Article/detail/591938?contextCategoryId=46551&ref=25 San Francisco—Refractive-cataract surgeons now have a tool to guide the outcomes of their cataract procedures (ORange Intraoperative Wavefront Aberrometer, WaveTec Vision). 2009-04-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/152009/591938null HTML http://www.modernmedicine.com/modernmedicine/Cataract/ASCRS-Binkhorst-Lecture-Three-programs-offer-hope-/ArticleStandard/Article/detail/591709?contextCategoryId=46551&ref=25 San Francisco—Three programs in different geographic areas of the world serve as models of success in addressing cataract, the top cause of blindness globally, said David F. Chang, MD, who delivered the Binkhorst Lecture during the opening session. 2009-04-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/152009/591709null HTML http://www.modernmedicine.com/modernmedicine/Cataract/ASCRS-Training-program-helps-surgeons-boost-premiu/ArticleStandard/Article/detail/591707?contextCategoryId=46551&ref=25 San Francisco—The first session of a unique training program, Premium Lens Boot Camp, to help refractive and cataract surgeons grow their accommodating/multifocal lens business will be held June 5 at the O'Hare Marriott, Chicago. 2009-04-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/142009/591707null HTML http://www.modernmedicine.com/modernmedicine/Cataract/ASCRS-3D-flat-panel-displays-available-for-operati/ArticleStandard/Article/detail/591706?contextCategoryId=46551&ref=25 San Francisco—New three-dimensional (3D) flat-panel displays (TrueVision Systems Inc.) will enable cataract and refractive surgeons to display live and recorded content of the surgical view from a microscope or slit lamp. 2009-04-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/142009/591706null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inhaled-and-Oral-Corticosteroid-Link-to-Cataracts-/ArticleNewsFeed/Article/detail/591521?contextCategoryId=46551&ref=25 Individuals who use both inhaled and oral corticosteroids may face increased long-term risks of posterior subcapsular cataracts and nuclear cataracts, according to research published in the April issue of Ophthalmology. 2009-04-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/142009/591521/eyechart.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/142009/591521null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Aspheric-toric-IOL-for-cataracts-is-approved-by-th/ArticleStandard/Article/detail/593669?contextCategoryId=46551&ref=25 Alcon Laboratories has gained FDA approval to market an aspheric version of its astigmatism-correcting IOL, the AcrySof IQ Toric IOL. With this new platform, cataract surgeons can continue to provide precise reduction of astigmatism and excellent distance visual acuity outcomes, while patients will benefit further with improved image quality and contrast sensitivity. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/162009/593669null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Outcomes-with-microcoaxial-versus-standard-coaxial/ArticleStandard/Article/detail/593672?contextCategoryId=46551&ref=25 Phacoemulsification using the OZil torsional handpiece and the INFINTI Vision System (Alcon Laboratories) was performed in 32 patients undergoing bilateral cataract surgery using a standard 2.8-mm coaxial incision in the right eye and a 2.2-mm microcoaxial incision in the left eye. There were statistically significant differences favoring the microcoaxial procedure in cumulative dissipated energy intraoperatively and endothelial cell loss after 6 months. These benefits were achieved without any compromise of incision integrity. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/162009/593672null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anterior-chamber-versus-suture-fixated-poster-cham/ArticleStandard/Article/detail/593671?contextCategoryId=46551&ref=25 There have been few trials adequately structured to compare different IOL options in eyes without adequate capsular bag support, and none provides clear evidence for the superiority of an anterior chamber, iris sutured posterior chamber (PC), or scleral sutured PC IOL. IOL selection should be based on surgeon experience and patient-related factors. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/162009/593671null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-surgery-outcomes-better-predicted-by-mete/ArticleStandard/Article/detail/593670?contextCategoryId=46551&ref=25 Patients undergoing phacoemulsification were evaluated preoperatively with a proprietary device (Retinal Acuity Meter, AMA Optics) and a dilated near card through a potential acuity pinhole technique. Predictions of postoperative distance acuity were significantly more accurate using the meter. Design features of the device that standardize testing conditions and eliminate patient confusion during reading likely account for its superior performance. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/162009/593670null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/sponsored-multimedia-Premium-Solutions-for-Catarac/ArticleStandard/Article/detail/589522?contextCategoryId=46551&ref=25 Premium Solutions for Cataract Surgery Video. Sponsored by Bausch and Lomb. In association with Ophthalmology Times. 2009-03-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/modernmedicine/132009/589522null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IOL-dislocation-management-differentiated-by-compl/ArticleStandard/Article/detail/589230?contextCategoryId=46551&ref=25 Approaches for managing a dislocated posterior chamber IOL each have their advantages and disadvantages. Results of a retrospective study including more than 300 eyes show that whether the IOL is exchanged or repositioned with suturing and whether the suturing is to the sclera or the iris, the functional outcome is similar on average, and safety is favorable. Complication profiles mainly distinguish the various techniques. 2009-03-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/132009/589230null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Nepafenac-regimens-demonstrate-efficacy-in-control/ArticleStandard/Article/detail/589242?contextCategoryId=46551&ref=25 A prospective, multicenter, randomized, double-masked, vehicle-controlled clinical trial of 212 patients investigated the efficacy and safety of nepafenac 0.1% ophthalmic suspension q.d., b.i.d., and t.i.d. for controlling pain and inflammation after cataract surgery. All three regimens were significantly superior to vehicle in the primary efficacy analysis. The t.i.d. dosing offered the fastest onset of action, but the b.i.d. and q.d. regimens demonstrated significant efficacy early after surgery as well. 2009-03-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/132009/589242null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/San-Francisco-to-host-annual-American-Society-of-C/ArticleStandard/Article/detail/589234?contextCategoryId=46551&ref=25 This popular Northern California city will again host the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, April 3 to 8. 2009-03-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/132009/589234null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Capsulorhexis-The-most-important-step-in-phacoemul/ArticleStandard/Article/detail/589231?contextCategoryId=46551&ref=25 The capsulorhexis is perhaps the most important step in phacoemulsification for guaranteeing a good outcome. A well-centered and adequately sized rhexis that overlaps the IOL optic slightly for 360° is the ideal and for the most part, this is easily achieved in routine cases. However, alterations in technique and sizing may be necessary or desirable in difficult and challenging cases such as advanced nuclear sclerosis, pseudoexfoliation, posterior polar cataract, or subluxed lenses. 2009-03-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/132009/589231null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Improved-cataract-surgery-lowers-infection-rates/ArticleStandard/Article/detail/585455?contextCategoryId=46551&ref=25 Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers. 2009-03-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/585455null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AMD-not-made-worse-by-cataract-surgery-according-t/ArticleStandard/Article/detail/584514?contextCategoryId=46551&ref=25 According to new research, cataract surgery does not hasten vision loss in people with age-related macular degeneration (AMD). 2009-03-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/584514null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Capsulorhexis-tear-out-salvaged-by-simple-maneuver/ArticleStandard/Article/detail/585656?contextCategoryId=46551&ref=25 When capsulorrhexis becomes complicated by a radial tear, pulling the flap backward, first circumferentially and then centrally, can rescue the tear-out. Here, an ophthalmologist shares a technique to successfully address this complication. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/585656null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IOP-lowering-benefits-of-cataract-surgery-more-sig/ArticleStandard/Article/detail/585655?contextCategoryId=46551&ref=25 Cataract surgery can dramatically lower elevated IOP, and the effect appears to be quite durable. This benefit, together with the safety of phacoemulsification, suggests that ophthalmologists should consider its role as a stand-alone procedure to treat co-morbid cataract and glaucoma. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/585655null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Cataracts-and-AMD-may-be-prevented-by-exercise-acc/ArticleStandard/Article/detail/582274?contextCategoryId=46551&ref=25 Vigorous exercise may help prevent age-related macular degeneration and cataracts, according to a new study. 2009-02-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582274null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/sponsored-multimedia-OnDemand-Premium-Solutions-fo/ArticleStandard/Article/detail/582293?contextCategoryId=46551&ref=25 OnDemand Premium Solutions for Cataract Surgery 2009-02-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/modernmedicine/082009/582293null HTML http://www.modernmedicine.com/modernmedicine/Cataract+News/Accommodating-IOL-ad-campaign-for-seniors-launched/ArticleStandard/Article/detail/579483?contextCategoryId=46551&ref=25 Bausch & Lomb launched a new advertising campaign geared toward baby boomers and seniors about its FDA-approved accommodating IOL (Crystalens). 2009-02-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/062009/579483null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Multifocal-IOL-is-approved-by-FDA/ArticleStandard/Article/detail/580293?contextCategoryId=46551&ref=25 The FDA approved a multifocal IOL (Tecnis, Advanced Medical Optics) for implantation in patients with cataract and presbyopia. 2009-02-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/062009/580293null XML http://www.modernmedicine.com/modernmedicine/Industry+News/FDA-approves-multifocal-IOL/ArticleStandard/Article/detail/576432?contextCategoryId=46551&ref=25 Advanced Medical Optics has received FDA approval for a multifocal IOL (Tecnis) for patients with cataracts. 2009-01-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/042009/576432null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Cataracts-could-be-detected-early-with-NASA-device/ArticleStandard/Article/detail/576381?contextCategoryId=46551&ref=25 Researchers are studying the use of a NASA device to reveal the development of cataracts before a patient's vision clouds over. 2009-01-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/042009/576381null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataracts-presbyopia-lens-approved-by-FDA/ArticleStandard/Article/detail/577630?contextCategoryId=46551&ref=25 The FDA last month approved a lens (AcrySof IQ ReSTOR +3 D, Alcon Laboratories) designed for implantation in patients with cataract and presbyopia. 2009-01-15T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/052009/577630null XML http://www.modernmedicine.com/modernmedicine/Cataract+News/Cataract-refractive-surgeons-become-editorial-advi/ArticleStandard/Article/detail/574459?contextCategoryId=46551&ref=25 Medical Management Services Group LLC have appointed both cataract and refractive surgeons as editorial advisors for 2009. 2009-01-08T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/022009/574459null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/FDA-approves-IOL-for-cataracts-and-presbyopia/ArticleStandard/Article/detail/574493?contextCategoryId=46551&ref=25 Alcon Inc. has received FDA approval for a lens designed for implantation during cataract surgery in patients with presbyopia (AcrySof IQ ReSTOR +3.0 D). 2009-01-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/022009/574493null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-staining-useful-aid-for-vitrectomy/ArticleStandard/Article/detail/573451?contextCategoryId=46551&ref=25 Intracameral injection of triamcinolone is very useful for "staining" vitreous that has prolapsed into the anterior segment to enable vitrectomy. Safety is favorable, but there are some issues to consider. 2009-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/012008/573451null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pars-plana-approach-can-provide-successful-outcome/ArticleStandard/Article/detail/573450?contextCategoryId=46551&ref=25 Posterior capsule rupture with vitreous prolapse remains one of the most serious intraoperative complications during cataract surgery. Louis D. "Skip" Nichamin, MD, describes the benefits and technique for anterior vitrectomy using a pars plana approach. 2009-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/012008/573450null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-surgery-online-educational-resource-launc/ArticleStandard/Article/detail/573455?contextCategoryId=46551&ref=25 Alcon Inc. has launched an online educational resource, www.cataractsurgery.com, for people who have cataracts, and their caregivers. 2009-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/012008/573455null XML http://www.modernmedicine.com/modernmedicine/Cataract+News/IOL-market-analytics-available-through-Reportlinke/ArticleStandard/Article/detail/572901?contextCategoryId=46551&ref=25 A world market research report is now available for IOLs through Reportlinker.com. 2008-12-22T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/522008/572901null HTML http://www.modernmedicine.com/modernmedicine/Cataract+News/Visual-impairment-due-to-cataract-affects-mostly-p/ArticleStandard/Article/detail/571961?contextCategoryId=46551&ref=25 People with cataract-induced visual impairment are more likely to live in poverty than those with normal sight, according to a study conducted in three developing countries—Kenya, the Philippines, and Bangladesh. 2008-12-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/512008/571961null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-2008-A-year-in-review/ArticleStandard/Article/detail/568130?contextCategoryId=46551&ref=25 Cataract surgery is a modern success story because of the advances in techniques and technology that have been made over the years. Excellent outcomes are becoming routine, and the field only continues to progress, thanks to a steady stream of innovations. Three cataract surgeons share their thoughts on some of the most noteworthy innovations and trends of 2008 and beyond. 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/482008/568130null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anticipate-silodosin-intraoperative-floppy-iris-sy/ArticleStandard/Article/detail/568123?contextCategoryId=46551&ref=25 History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia. 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/482008/568123null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Cataract-surgery-Benefits-on-IOP-more-significant-/ArticleStandard/Article/detail/565102?contextCategoryId=46551&ref=25 Instead of combined surgery, cataract extraction alone by phacoemulsification through a clear corneal incision with posterior chamber IOL implantation may be the most appropriate procedure for patients with controlled or modestly uncontrolled glaucoma as well as for patients with ocular hypertension or glaucoma suspects, said Richard L. Lindstrom, MD, in his delivery of the Kelman Lecture during the Spotlight on Cataract Surgery session of the annual meeting of the American Academy of Ophthalmology. 2008-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/462008/565102null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AAO-Pars-plana-approach-preferred-for-anterior-vit/ArticleStandard/Article/detail/565103?contextCategoryId=46551&ref=25 If the posterior capsule breaks during cataract surgery and vitreous presents to the anterior chamber, patients are best served by anterior vitrectomy using a pars plana technique, said Louis "Skip" Nichamin, MD, medical director, Laurel Eye Clinic, Brookville, PA. 2008-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/462008/565103null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Tips-and-techniques-for-cataract-and-refractive-su/ArticleStandard/Article/detail/565094?contextCategoryId=46551&ref=25 Dry eye disease and cataract and refractive surgery are intertwined closely. Pre-existing dry eye can affect surgical outcomes and, in severe cases, is a contraindication for surgery, whereas surgery causes trauma to the ocular surface and may lead to signs and symptoms of dry eye. To break this cycle, a two-pronged approach of treating dry eye before surgery and taking steps to prevent its development postoperatively is advisable. 2008-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/462008/565094null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AAO-Simple-measures-improve-cataract-surgery-outco/ArticleStandard/Article/detail/565104?contextCategoryId=46551&ref=25 The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, offered several tips for achieving better refractive outcomes in this growing population of eyes. 2008-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/462008/565104null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AAO-Favorable-outcomes-achieved-after-toric-IOL-im/ArticleStandard/Article/detail/564727?contextCategoryId=46551&ref=25 Implantation of a toric IOL appears to be a safe and effective method for correcting spherical error and astigmatism in eyes with cataract and a history of penetrating keratoplasty, said Renée D. Solomon, MD. 2008-11-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/462008/564727null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AAO-Premium-solutions-for-cataract-surgery/ArticleStandard/Article/detail/564635?contextCategoryId=46551&ref=25 In a series of presentations, speakers at an educational program outlined the benefits of technologies for premium cataract surgery including a microincision platform (Stellaris Vision Enhancement System), an accommodating IOL (the Crystalens HD), and an advanced optics aspheric lens (Akreos), all from Bausch & Lomb. The evening program, held at the Georgia Aquarium, also featured two live cataract surgery cases performed in Beverly Hills, CA, by Uday Devgan, MD. 2008-11-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452008/564635null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Anticipate-silodosin-IFIS-link-surgeon-says/ArticleStandard/Article/detail/563092?contextCategoryId=46551&ref=25 History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia. 2008-11-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452008/563092null HTML